Fibrinolytic activity in malignant disease.
Open Access
- 1 November 1975
- journal article
- research article
- Published by BMJ in Journal of Clinical Pathology
- Vol. 28 (11) , 872-874
- https://doi.org/10.1136/jcp.28.11.872
Abstract
Resting fibrinolytic activity and fibrinolytic capacity were compared in 31 patients with malignant disease and in 24 control subjects without malignant disease. Patients with malignant disease had a lower mean fibrinolytic activity: this was particularly marked in those with disseminated disease. In contrast, patients with malignant disease had a fibrinolytic capacity which did not differ from that of the control subjects.Keywords
This publication has 10 references indexed in Scilit:
- "Fibrinolytic capacity" in healthy volunteers as estimated from effect of venous occlusion of arms.1972
- The fibrinolytic enzyme system in hepatic cirrhosis and malignant metastasesJournal of Clinical Pathology, 1971
- Coagulation disorders in cancer. III.Fibrinolysis and inhibitorsCancer, 1970
- FIBRINOLYTIC ACTIVITY OF HUMAN VEINSThe Lancet, 1967
- Fibrinolysis and carcinoma of the prostateJournal of Clinical Pathology, 1965
- The histological localisation of fibrinolysin activatorThe Journal of Pathology and Bacteriology, 1959
- STUDIES ON ENHANCED FIBRINOLYTIC ACTIVITY IN MAN*Journal of Clinical Investigation, 1959
- Urokinase an activator of plasminogen from human urine I. Isolation and propertiesBiochimica et Biophysica Acta, 1957
- The significance of fibrinolysis occurring in patients with metastatic cancer of the prostateCancer, 1953
- Fibrinolysis in metastatic cancer of the prostateCancer, 1952